Clinical Trial Detail

NCT ID NCT02188550
Title Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Sinai Hospital of Baltimore

fallopian tube carcinoma

ovary epithelial cancer

endometrial cancer

peritoneal carcinoma


Everolimus + Letrozole

Age Groups: adult

No variant requirements are available.